This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as First Principals, Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, Bioject Medical Technologies, Inc., Covidien Plc, Crossject Ltd., D'Antonio Consultants International, Inc., Glide Pharmaceutical Technologies Ltd., Incline Therapeutics, Inc., INJEX Pharma GmbH, Medical International Technologies (Mit Canada), Inc., National Medical Products, Inc., PenJet Corporation, PowderJect Pharmaceuticals Plc, Retractable Technologies, Inc., Safety Syringes, Inc., Smiths Group, Smiths Medical, Terumo Corporation, Unilife Medical Solutions Ltd., Valeritas, Ypsomed Holding AG, and Zogenix, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.